Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ocaratuzumab (AME 133v), an Fc-engineered humanized IgG1 anti-CD20 monoclonal antibody, demonstrates enhanced antibody-dependent cell-mediated cytotoxicity (ADCC) [1] [2] with a dissociation constant (Kd) of approximately 100 pM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $290 | 2-4 weeks | |
5 mg | $755 | 2-4 weeks | |
10 mg | $1,200 | 2-4 weeks |
Description | Ocaratuzumab (AME 133v), an Fc-engineered humanized IgG1 anti-CD20 monoclonal antibody, demonstrates enhanced antibody-dependent cell-mediated cytotoxicity (ADCC) [1] [2] with a dissociation constant (Kd) of approximately 100 pM. |
Cas No. | 1169956-08-4 |
Storage | store at -80°C | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.